New drug pricing policy is triggering backlash

Published: 2007-01-11 07:00:00

Updated: 2007-01-11 07:00:00

The Korea Pharmaceutical Manufacturers Association (KPMA) said on January 10 that all of its members will soon rely on legal means to stop the new drug-pricing policy from going into effect, saying that the new system will badly affect their profitability.

With the new drug-pricing policy syst...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK